Advanced Search
Gu Mofa, He Weiling, Chen Xinlin, Xiao Weiwei, Su Yong, He Zhenyu, Li Jianjun, Zhang Huaman. Measurement Psychology Assessment for Quality of Life Evaluated by QLQ-C30 in Patients with Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2012, 39(09): 1079-1082. DOI: 10.3971/j.issn.1000-8578.2012.09.009
Citation: Gu Mofa, He Weiling, Chen Xinlin, Xiao Weiwei, Su Yong, He Zhenyu, Li Jianjun, Zhang Huaman. Measurement Psychology Assessment for Quality of Life Evaluated by QLQ-C30 in Patients with Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2012, 39(09): 1079-1082. DOI: 10.3971/j.issn.1000-8578.2012.09.009

Measurement Psychology Assessment for Quality of Life Evaluated by QLQ-C30 in Patients with Nasopharyngeal Carcinoma

More Information
  • Received Date: October 31, 2011
  • Revised Date: May 08, 2012
  • Objective To assess the psychological characteristic of EORTC QLQ-C30 scale;and to measure whether QLQ-C30 scale was suitable to measure the QOL of nasopharyngeal carcinoma(NPC) patients. Methods The data of 391 NPC patients from Cancer Hospital of Sun Yat-Sen University were collected.The reliability,validity and discrimination of scale were assessed by reliability and validity theory.And differential item functioning(DIF) was reviewed by item response theory evaluation. ResultsCronbach′s α coefficients of QLQ-C30 domains were greater than 0.7,except physical function and cognitive function domain.Split-half reliability of QLQ-C30 domains was greater than 0.7,except physical function domain and fatigue.Test-retest coefficients of QLQ-C30 domains were greater than 0.7.The result of factor analysis showed that the data were consistent with the theoretical model.Most of the domain scores and dimension scores of patients in different radiotherapy stages were significantly different(P<0.05).All the items had not uniform or non-uniform DIF between different gender and age groups. Conclusion QLQ-C30 scale was a reliable and valid disease-specific instrument,with good receptiveness to evaluate QOL of NPC patients.
  • [1]
    Wan DS.Clinical oncology [M].Beijing:Science Press,2005:217-29.[万德森.临床肿瘤学[M].北京:科学出版社,2005:217-29.]
    [2]
    Luo J,Chu DT.To evaluate the effect of quality of life in Chinese herbal drugs to treat tumour[J].Zhonghua Zhong Liu Za Zhi,2002,24(4):411-3.[罗健,储大同.评价生活质量在中医药治疗恶性肿瘤中的作用[J].中华肿瘤杂志,2002,24(4):411-3.]
    [3]
    Aaronson NK,Ahmedzai S,Bergman B,et al.The European Organization for Research and Treatment of Cancer QLQ-C30:a quality-of-life instrument for use in international clinical trials in oncology [J].J Natl CancerInst,1993,85(5):365-76.
    [4]
    Aaronson NK,Cull A,Kaasa S,et al.The EORTC modular approach to quality of life assessment in oncology:anupdate.In Quality of life and pharmacoeconomics in clinical trials[M].2nd edition(B.Spilker,ed).Philadelphia:Lippincott-Raven Publishers,1996:179-89.
    [5]
    Wan CH,Chen MQ,Zhang CZ,et al.The evaluation of Chinese version of European Organization for research andtreatment(EORTC) QLQ-C30[J].Shi Yong Zhong Liu Za Zhi[J].2005,20(4):353-5.[万崇华,陈明清,张灿珍,等.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-5.]
    [6]
    Li ZP,He YM,Shen HY,et al.Research on QOL of cancer survivor in Tongzhou county of Jiangsu province[J].Zhong Liu Fang Zhi Yan Jiu,2011,38(6):701-4.[李中平,何裕民,沈红艺,等.江苏省通州地区肿瘤患者生存质量的研究[J].肿瘤防治研究,2011,38(6):701-4.]
    [7]
    Chen XL,Gu MF,Tong Q,et al.Application of item response theory to the characteristics evaluation of SF-36scale [J].Zhongguo Man Xing Bing Yu Fang Yu Kong Zhi,2010,18(5):444-7.[陈新林,古模发,童琴,等.项目反应理论在SF-36心理测量学特征评价中的应用[J].中国慢性病预防与控制,2010,18(5):444-7.]
    [8]
    Cella D,Chang CH.A discussion of item response theory and its applications in health status assessment [J].Med Care,2000,38(9 Supp1):1166-72.
  • Related Articles

    [1]LI Zhong. Idea of Synergistic and Comprehensive Treatment of Malignant Tumors with Traditional Chinese Medicine Discussed from Theory of “Cancer State”[J]. Cancer Research on Prevention and Treatment, 2025, 52(1): 7-10. DOI: 10.3971/j.issn.1000-8578.2025.24.0771
    [2]ZHANG Peng, YANG Qian, YI Dongfeng. Construction and Validation of A Risk Model for Predicting Prognosis and Immunotherapy Response of Bladder Cancer Based on Cellular Senescence-related Genes[J]. Cancer Research on Prevention and Treatment, 2023, 50(4): 384-389. DOI: 10.3971/j.issn.1000-8578.2023.22.1214
    [3]LU Wenping. Exploration of Peritoneal Metastasis of Advanced Ovarian Cancer and Maintenance Treatment with Traditional Chinese Medicine Based on Theory of Membranous Sanjiao[J]. Cancer Research on Prevention and Treatment, 2022, 49(8): 756-759. DOI: 10.3971/j.issn.1000-8578.2022.22.0106
    [4]LUO Wenqing, LI Yuanqi, YE Fei, LI Qiangming, ZHANG Guoqing, LI Xiangnan. Construction and Validation of A Nomogram Prognostic Model for Patients with Lung Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2022, 49(3): 197-204. DOI: 10.3971/j.issn.1000-8578.2022.21.0623
    [5]HU Lanping, QIU Dasheng. Current Status of Imaging Assessment of Cancer Response to Immunotherapy[J]. Cancer Research on Prevention and Treatment, 2021, 48(12): 1118-1122. DOI: 10.3971/j.issn.1000-8578.2021.21.0320
    [6]ZHAO Xiaopeng, YAN Chao, DU Hongzhen, XIE Ying, LUO Bin, LI Zengning. Reliability and Validity Research of Chinese Version of Cancer Appetite and Symptom Questionnaire[J]. Cancer Research on Prevention and Treatment, 2018, 45(11): 874-878. DOI: 10.3971/j.issn.1000-8578.2018.18.0194
    [7]LI Xiaohua, MENG Yiliang, ZHAO Lijuan, HUANG Chengle, HUANG Julue, QI Guangzi. Epstein-barr Virus Antibodies Response for Zhuang NPC Patients of Different Ages[J]. Cancer Research on Prevention and Treatment, 2013, 40(04): 377-380. DOI: 10.3971/j.issn.1000-8578.2013.04.014
    [8]QI Chu-bo, ZHU Run-qing, XIA He-shun, WANG Ming-wei. A Simple Making Method of Tissue Microarray and Validation Study on Immunohistochemistry[J]. Cancer Research on Prevention and Treatment, 2007, 34(08): 629-632. DOI: 10.3971/j.issn.1000-8578.1224
    [9]GE Wei, NU Xiao-hui Renmin. Evaluation of lymph node response to neoadjuvant chemotherapy in untreated nasopharyngeal carcinoma[J]. Cancer Research on Prevention and Treatment, 2003, 30(06): 502-504. DOI: 10.3971/j.issn.1000-8578.2924
    [10]Wang ZhiPing, . LOCAL IMMUNOLOGIC RESPONSE OF MAST CELL IN BLADDER CANCER[J]. Cancer Research on Prevention and Treatment, 1990, 17(1): 34-35.

Catalog

    Zhang Huaman

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (4008) PDF downloads (669) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return